vsao Journal Nr. 4 - August 2021

Perspektiven
Literatur (Fortsetzung)
a systematic review and meta-analysis.
Lancet Neurol. 2015; 14:
162 – 73.
23. National Institute for
Health and Care Excellence, ed.
NICE Clinical Guideline [Internet].
London: National Institute for
Health and Care Excellence; 2013
Nov 20 [cited 2020 March 23].
Available from: https://www.nice.
org.uk/guidance/cg173
24. Schlereth T, et al.
Diagnose und nicht interventionelle
Therapie neuropathischer
Schmerzen, S2k-Leitlinie, 2019. In:
Deutsche Gesellschaft für
Neurologie, Hrsg. Leitlinien für
Diagnostik und Therapie in der
Neurologie [Internet]. [abgerufen
am 23. März 2020]. Verfügbar
unter: www.dgn.org/leitlinien
25. International Association
for the Study of Pain, ed. IASP
Statement on Opioids [Internet].
2018 Feb [cited 2020 March 23].
Available from: https://www.
iasp-pain.org/Advocacy/
OpioidPositionStatement
26. International Association
for the Study of Pain, ed. IASP
Council Approves Statement on
Appropriate Use of Opioids
[Internet]. 2018 Feb 20 [cited 2020
March 23]. Available from: https://
www.iasp-pain.org/Publications-
News/NewsDetail.aspx?
ItemNumber=7221
27. Häuser W, Ziegler D,
Viniol A, Schäfer M, Hupfer K,
Freys S, et al. 2. Aktualisierung der
S3 Leitlinie «Langzeitanwendungen
von Opioiden bei chronischen
nicht-tumorbedingten Schmerzen
(LONTS)». Schmerz 2020; 34: in
press.
28. Searle RD, Howell SJ,
Bennet MI. Diagnosing postoperative
neuropathic pain: A Delphi
survey. Br J Anaesth. 2012; 109:
240 – 4.
29. Orhurhu V, Orhurhu
MS, Bhatia A, Cohen SP. Ketamine
Infusions for Chronic Pain: A
Systematic Review and Meta-analysis
of Randomized Controlled
Trials. Anesth Analg. 2019; 129:
241 – 54.
30. Deer TR, Pope JE,
Hanes MC, McDowell GC.
Intrathecal Therapy for Chronic
Pain: A Review of Morphine and
Ziconotide as Firstline Options.
Pain Med. 2019;20:784 – 98.
31. Teasell RW, Mehta S,
Aubut JA, Foulon B, Wolfe DL,
Hsieh JT, et al. A systematic review
of pharmacologic treatments of
pain after spinal cord injury. Arch
Phys Med Rehabil. 2010; 91:
816 – 31.
32. Abboud H, Hill E,
Siddiqui J, Serra A, Walter B.
Neuromodulation in multiple
sclerosis. Mult Scler. 2017; 23:
1663 – 76.
33. Birklein F, et al.
Diagnostik und Therapie
komplexer regionaler Schmerzsyndrome
(CRPS), S1-Leitlinie, 2018.
In: Deutsche Gesellschaft für
Neurologie, Hrsg. Leitlinien für
Diagnostik und Therapie in der
Neurologie [Internet]. [abgerufen
am 23. März 2020] Verfügbar unter:
www.dgn.org/leitlinien
34. van der Plas AA, van
Rijn MA, Marinus J, Putter H, van
Hilten JJ. Efficacy of intrathecal
baclofen on different pain qualities
in complex regional pain
syndrome. Anesth Analg. 2018; 116:
211 – 5.
35. Gruccu G, Truini A. A
review of Neuropathic Pain: From
Guidelines to Clinical Practice.
Pain Ther. 2017; 6: 35 – 42.
36. Kane, N. Capsaicin
patch for neuropathic pain
(update) [Internet]. Newcastle:
Regional Drug & Therapeutics
Centre; 2016 [cited 2020 March 23].
Available from: http://ntag.nhs.uk/
docs/app/Qutenza%20NTAG%20
Appraisal%20update%20for%20
web.pdf
37. Kern KU, Weiser T.
Topical ambroxol for the treatment
of neuropathic pain. An initial clinical
observation. Schmerz. 2015; 29:
89 – 96.
38. Chronic non-malignant
pain. In: Bandolier.org.uk
[Internet]. [cited 2020 March 23].
Available from http://www.
bandolier.org.uk/booth/painpag/
chronic.html
39. Tremont-Lukats IW,
Hutson PR, Backonja M. A
randomized, double-masked,
placebo-controlled pilot trial of
extended IV lidocaine infusion for
relief of ongoing neuropathic pain.
Clin J Pain. 2006; 22: 266 – 71.
40. Iacob E, Hagn EE, Sindt
J, Brogan S, Tadler S, Kennington
KS, et al. Tertiary Care Clinical
Experience with Intravenous
Lidocaine Infusions for the
Treatment of Chronic Pain. Pain
Med. 2018; 19: 1245 – 53.
41. Beloeil H, Sion B,
Rousseau C, Albaladejo P, Raux M,
Aubrun F, Martinez V. Early
postoperative neuropathic pain
assessed by the DN4 score predicts
an increased risk of persistent
postsurgical neuropathic pain. Eur
J Anaesthesiol. 2017;34:652 – 7.
42. Jaksch W, Likar R,
Aigner M. Ketamine in the therapy
of chronic pain and depression.
Wien Med Wochenschr. 2019; 169:
367 – 76.
vsao /asmac Journal 4/21 53